acetazolamide has been researched along with Bronchial Neoplasms in 2 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Bronchial Neoplasms: Tumors or cancer of the BRONCHI.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bronchial carcinoids are neuroendocrine tumors that present as typical (TC) and atypical (AC) variants, the latter being more aggressive, invasive and metastatic." | 5.51 | Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphane. ( Baluch, N; Bayat Mokhtari, R; Cheng, HL; Das, B; Kumar, S; Morgatskaya, E; Muscarella, LA; Sparaneo, A; Yeger, H; Zhao, S, 2019) |
| "Bronchial carcinoids are neuroendocrine tumors that present as typical (TC) and atypical (AC) variants, the latter being more aggressive, invasive and metastatic." | 1.51 | Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphane. ( Baluch, N; Bayat Mokhtari, R; Cheng, HL; Das, B; Kumar, S; Morgatskaya, E; Muscarella, LA; Sparaneo, A; Yeger, H; Zhao, S, 2019) |
| "In vitro studies were used for the dose-response (AlamarBlue) effects of acetazolamide (AZ) and sulforaphane (SFN) on clonogenicity, serotonin-induced growth effect and serotonin content (LC-MS) on H-727 (TC) and H-720 (AC) bronchial carcinoid cell lines and their derived NOD/SCID mice subcutaneous xenografts." | 1.39 | Combination of carbonic anhydrase inhibitor, acetazolamide, and sulforaphane, reduces the viability and growth of bronchial carcinoid cell lines. ( Adeli, K; Cutz, E; Islam, SS; Kumar, S; Mokhtari, RB; Yazdanpanah, M; Yeger, H, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayat Mokhtari, R | 1 |
| Baluch, N | 1 |
| Morgatskaya, E | 1 |
| Kumar, S | 2 |
| Sparaneo, A | 1 |
| Muscarella, LA | 1 |
| Zhao, S | 1 |
| Cheng, HL | 1 |
| Das, B | 1 |
| Yeger, H | 2 |
| Mokhtari, RB | 1 |
| Islam, SS | 1 |
| Yazdanpanah, M | 1 |
| Adeli, K | 1 |
| Cutz, E | 1 |
2 other studies available for acetazolamide and Bronchial Neoplasms
| Article | Year |
|---|---|
Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphane.
Topics: Acetazolamide; Animals; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Bro | 2019 |
Combination of carbonic anhydrase inhibitor, acetazolamide, and sulforaphane, reduces the viability and growth of bronchial carcinoid cell lines.
Topics: Acetazolamide; Animals; Antineoplastic Agents; Bronchial Neoplasms; Carbonic Anhydrase Inhibitors; C | 2013 |